On ECHEMI
Home > Drugs > Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

  • Founded in:

    2000-02-22
  • Country:

    China China
  • Address:

    No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industrial Park, Yangzhou City, Jiangsu Province
  • Tax NO.:

    91321000714094280W
  • Registered Funds:

    285.45627 million yuan
  • Website:

  • Email:

Related Drugs
Metformin and Gliclazide Tablets
This product is a compound preparation, its components are metformin hydrochloride and gliclazide.
Name Description Content CAS NO. Registered Holders
1,1-DIMETHYLBIGUANIDE HYDROCHLORIDE

Improve the sensitivity of liver and peripheral tissues to insulin, improve glucose uptake and utilization. It may also have the effect of improving blood lipid levels and fibrinolytic protein activity.

More

Improve the sensitivity of liver and peripheral tissues to insulin, improve glucose uptake and utilization. It may also have the effect of improving blood lipid levels and fibrinolytic protein activity.

15537-72-1 55
Gliclazide

It can stimulate pancreatic β cells to secrete insulin. Its mechanism of action is to specifically bind to the sulfonylurea receptors on the β cell membrane, thereby closing the potassium ion channel and causing a change in membrane potential. As a result, the calcium ion channel opens, and the calcium ions in the cytosol increase, prompting the secretion of insulin. It also has an extrapancreatic effect, which can reduce the liver's insulin resistance to peripheral tissues (muscle, fat). In addition, gliclazide can also reduce platelet adhesion and aggregation, and has fibrinolytic activity.

More

It can stimulate pancreatic β cells to secrete insulin. Its mechanism of action is to specifically bind to the sulfonylurea receptors on the β cell membrane, thereby closing the potassium ion channel and causing a change in membrane potential. As a result, the calcium ion channel opens, and the calcium ions in the cytosol increase, prompting the secretion of insulin. It also has an extrapancreatic effect, which can reduce the liver's insulin resistance to peripheral tissues (muscle, fat). In addition, gliclazide can also reduce platelet adhesion and aggregation, and has fibrinolytic activity.

21187-98-4 22
Aminobenzoic acid injection
Chemical name: 6-aminohexanoic acid
Name Description Content CAS NO. Registered Holders
6-Aminocaproic acid

This product is an antifibrinolytic drug. It competitively inhibits plasminogen with the fibrin binding site, preventing it from activating into plasmin, thereby inhibiting fibrinolysis; at high concentrations, it directly inhibits the activity of plasmin and achieves a hemostatic effect.

More

This product is an antifibrinolytic drug. It competitively inhibits plasminogen with the fibrin binding site, preventing it from activating into plasmin, thereby inhibiting fibrinolysis; at high concentrations, it directly inhibits the activity of plasmin and achieves a hemostatic effect.

60-32-2 6
Methylcobalamin Injection
The main ingredient of this product is methylcobalamin, and its chemical name is: Coα-[α-(5,6-dimethylbenzimidazolyl)]-Coβ-methylcobaltamide.
Name Description Content CAS NO. Registered Holders
Mecobalamin

Methylcobalamin is an endogenous coenzyme B12. It plays an important role as a coenzyme of methionine synthase in the transmethylation reaction of methionine synthesized from homocysteine. It is easily transferred to the organelles of nerve cells, thereby promoting the synthesis of nucleic acids and proteins. It is easier to transfer into the organelles of nerve cells than cyanocobalamin, and participates in the process of synthesizing thymidine from deoxyuridine in brain cells and spinal cord nerve cells, promoting the utilization of folic acid and the metabolism of nucleic acids. It can promote the synthesis of nucleic acids and proteins better than cobalamin, and promotes intra-axonal transport and axonal regeneration.

More

Methylcobalamin is an endogenous coenzyme B12. It plays an important role as a coenzyme of methionine synthase in the transmethylation reaction of methionine synthesized from homocysteine. It is easily transferred to the organelles of nerve cells, thereby promoting the synthesis of nucleic acids and proteins. It is easier to transfer into the organelles of nerve cells than cyanocobalamin, and participates in the process of synthesizing thymidine from deoxyuridine in brain cells and spinal cord nerve cells, promoting the utilization of folic acid and the metabolism of nucleic acids. It can promote the synthesis of nucleic acids and proteins better than cobalamin, and promotes intra-axonal transport and axonal regeneration.

13422-55-4 29
Acetylglutamine for injection
The main ingredient of this product is acetylglutamine.
Name Description Content CAS NO. Registered Holders
Aceglutamide

After passing through the blood-brain-spinal fluid barrier, it is decomposed into glutamate and g-aminobutyric acid (GABA); glutamate is involved in information transmission in the central nervous system; g-aminobutyric acid can antagonize the excitotoxic effects of glutamate, improve nerve cell metabolism, maintain nerve stress resistance, reduce the effects of blood ammonia, and improve brain function.

More

After passing through the blood-brain-spinal fluid barrier, it is decomposed into glutamate and g-aminobutyric acid (GABA); glutamate is involved in information transmission in the central nervous system; g-aminobutyric acid can antagonize the excitotoxic effects of glutamate, improve nerve cell metabolism, maintain nerve stress resistance, reduce the effects of blood ammonia, and improve brain function.

2490-97-3 6
Dexamethasone acetate
Name Description Content CAS NO. Registered Holders
Dexamethasone-17-acetate

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

1177-87-3 13
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.